Latest Stock Split Details
Key information about Hubei Biocause Pharmaceutical Co., Ltd.'s most recent stock split
Split Date: 2010-04-12
Split Ratio: 37:20
Price Before Split: $11.65
Price After Split: $6.30
Developer API
Get 000627.SZ split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/000627.SZ
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.85 times more shares (a 37:20 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Hubei Biocause Pharmaceutical Co., Ltd.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2010-04-12 | 37:20 | No | $11.65 | $6.30 |
| 2005-11-09 | 33:25 | No | $2.37 | $1.79 |
| 2002-06-12 | 23:20 | No | $13.97 | $12.15 |
| 2001-09-24 | 3:2 | No | $21.34 | $14.23 |
| 2001-05-23 | 59649:50000 | No | $23.72 | $19.88 |
| 2000-05-16 | 6:5 | No | $23.68 | $19.73 |
| 1999-09-07 | 9:5 | No | $25.67 | $14.26 |
| 1996-12-27 | 2:1 | No | $57.50 | $28.75 |
About Hubei Biocause Pharmaceutical Co., Ltd.
Company overview and industry information
Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) operates in the Insurance - Life industry. The recent 37-for-20 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Insurance - Life
Go to Hubei Biocause Pharmaceutical Co., Ltd. Summary